Close this search box.

New CEOs for Enable, StromaCare

ARTICLE | Management Tracks

Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

February 14, 2024 1:37 AM UTC

Drug discovery company Enable Medicine Inc. named Kamni Vijay as CEO, succeeding Sunil Bodapati, who will become chief strategy officer while remaining chairman. Vijay was VP and general manager at Becton Dickinson and Co. (NYSE:BDX) and at Bio-Techne Corp. (NASDAQ:TECH). 

StromaCare, a French company developing cancer therapies through stroma modulation, hired Georges Rawadi as CEO. Rawadi was CEO of Celyad Oncology S.A. (Euronext:CYAD; Pink:CYADY) and Ysopia Biosciences S.A. …